{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:24:54Z","timestamp":1761863094275},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,3,14]],"date-time":"2012-03-14T00:00:00Z","timestamp":1331683200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Intervent Radiol"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s00270-012-0370-8","type":"journal-article","created":{"date-parts":[[2012,3,13]],"date-time":"2012-03-13T16:29:58Z","timestamp":1331656198000},"page":"90-97","source":"Crossref","is-referenced-by-count":14,"title":["Cost-Effectiveness Analysis of Infrapopliteal Drug-Eluting Stents"],"prefix":"10.1007","volume":"36","author":[{"given":"Konstantinos","family":"Katsanos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitris","family":"Karnabatidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanasios","family":"Diamantopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stavros","family":"Spiliopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitris","family":"Siablis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,3,14]]},"reference":[{"issue":"4","key":"370_CR1","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.jvs.2010.10.088","volume":"53","author":"MF Conrad","year":"2011","unstructured":"Conrad MF, Crawford RS, Hackney LA et al (2011) Endovascular management of patients with critical limb ischemia: long-term results. J Vasc Surg 53(4):1020\u20131025","journal-title":"J Vasc Surg"},{"issue":"24","key":"370_CR2","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1161\/01.CIR.0000078025.19258.28","volume":"107","author":"PA Lemos","year":"2003","unstructured":"Lemos PA, Serruys PW, Sousa JE (2003) Drug-eluting stents: cost versus clinical benefit. Circulation 107(24):3003\u20133007","journal-title":"Circulation"},{"issue":"4","key":"370_CR3","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1583\/10-3073C.1","volume":"17","author":"D Siablis","year":"2010","unstructured":"Siablis D, Katsanos K, Karnabatidis D (2010) Commentary: infrapopliteal angioplasty with drug-eluting stents: from heart to toe. J Endovasc Ther 17(4):488\u2013491","journal-title":"J Endovasc Ther"},{"issue":"Suppl 1","key":"370_CR4","first-page":"I153","volume":"16","author":"D Karnabatidis","year":"2009","unstructured":"Karnabatidis D, Katsanos K, Siablis D (2009) Infrapopliteal stents: overview and unresolved issues. J Endovasc Ther 16(Suppl 1):I153\u2013I162","journal-title":"J Endovasc Ther"},{"issue":"11","key":"370_CR5","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.jvir.2007.07.018","volume":"18","author":"D Siablis","year":"2007","unstructured":"Siablis D, Karnabatidis D, Katsanos K, Diamantopoulos A, Christeas N, Kagadis GC (2007) Infrapopliteal application of paclitaxel-eluting stents for critical limb ischemia: midterm angiographic and clinical results. J Vasc Interv Radiol 18(11):1351\u20131361","journal-title":"J Vasc Interv Radiol"},{"issue":"4","key":"370_CR6","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1007\/s00330-008-1225-1","volume":"19","author":"A Falkowski","year":"2009","unstructured":"Falkowski A, Poncyljusz W, Wilk G, Szczerbo-Trojanowska M (2009) The evaluation of primary stenting of sirolimus-eluting versus bare-metal stents in the treatment of atherosclerotic lesions of crural arteries. Eur Radiol 19(4):966\u2013974","journal-title":"Eur Radiol"},{"issue":"15","key":"370_CR7","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.jacc.2009.11.072","volume":"55","author":"AJ Feiring","year":"2011","unstructured":"Feiring AJ, Krahn M, Nelson L, Wesolowski A, Eastwood D, Szabo A (2011) Preventing leg amputations in critical limb ischemia with below-the-knee drug-eluting stents: the PaRADISE (PReventing Amputations using Drug eluting StEnts) trial. J Am Coll Cardiol 55(15):1580\u20131589","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"370_CR8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1583\/1545-1550(2007)14[241:SVBSAS]2.0.CO;2","volume":"14","author":"D Siablis","year":"2007","unstructured":"Siablis D, Karnabatidis D, Katsanos K et al (2007) Sirolimus-eluting versus bare stents after suboptimal infrapopliteal angioplasty for critical limb ischemia: enduring 1-year angiographic and clinical benefit. J Endovasc Ther 14(2):241\u2013250","journal-title":"J Endovasc Ther"},{"issue":"6","key":"370_CR9","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1583\/05-1620MR.1","volume":"12","author":"D Siablis","year":"2005","unstructured":"Siablis D, Kraniotis P, Karnabatidis D, Kagadis GC, Katsanos K, Tsolakis J (2005) Sirolimus-eluting versus bare stents for bailout after suboptimal infrapopliteal angioplasty for critical limb ischemia: 6-month angiographic results from a nonrandomized prospective single-center study. J Endovasc Ther 12(6):685\u2013695","journal-title":"J Endovasc Ther"},{"issue":"1","key":"370_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1583\/10-3242.1","volume":"18","author":"D Karnabatidis","year":"2011","unstructured":"Karnabatidis D, Spiliopoulos S, Diamantopoulos A et al (2011) Primary everolimus-eluting stenting versus balloon angioplasty with bailout bare metal stenting of long infrapopliteal lesions for treatment of critical limb ischemia. J Endovasc Ther 18(1):1\u201312","journal-title":"J Endovasc Ther"},{"issue":"9","key":"370_CR11","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.jvir.2009.05.031","volume":"20","author":"D Siablis","year":"2009","unstructured":"Siablis D, Karnabatidis D, Katsanos K et al (2009) Infrapopliteal application of sirolimus-eluting versus bare metal stents for critical limb ischemia: analysis of long-term angiographic and clinical outcome. J Vasc Interv Radiol 20(9):1141\u20131150","journal-title":"J Vasc Interv Radiol"},{"issue":"1","key":"370_CR12","first-page":"55","volume":"56","author":"G Biondi-Zoccai","year":"2008","unstructured":"Biondi-Zoccai G, Lotrionte M, Moretti C et al (2008) Percutaneous coronary intervention with everolimus-eluting stents (Xience V): systematic review and direct-indirect comparison meta-analyses with paclitaxel-eluting stents (Taxus) and sirolimus-eluting stents (Cypher). Minerva Cardioangiol 56(1):55\u201365","journal-title":"Minerva Cardioangiol"},{"issue":"1","key":"370_CR13","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijcard.2011.01.015","volume":"150","author":"S Cassese","year":"2011","unstructured":"Cassese S, Piccolo R, Galasso G, De Rosa R, Piscione F (2011) Twelve-month clinical outcomes of everolimus-eluting stent as compared to paclitaxel- and sirolimus-eluting stent in patients undergoing percutaneous coronary interventions. A meta-analysis of randomized clinical trials. Int J Cardiol 150(1):84\u201389","journal-title":"Int J Cardiol"},{"issue":"1N","key":"370_CR14","first-page":"16N","volume":"88","author":"JJ Popma","year":"1990","unstructured":"Popma JJ, Topol EJ (1990) Factors influencing restenosis after coronary angioplasty. Am J Med 88(1N):16N\u201324N","journal-title":"Am J Med"},{"issue":"10","key":"370_CR15","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/clc.4960141004","volume":"14","author":"SP Karas","year":"1991","unstructured":"Karas SP, Santoian EC, Gravanis MB (1991) Restenosis following coronary angioplasty. Clin Cardiol 14(10):791\u2013801","journal-title":"Clin Cardiol"},{"issue":"4","key":"370_CR16","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1583\/10-3073.1","volume":"17","author":"A Rastan","year":"2010","unstructured":"Rastan A, Schwarzwalder U, Noory E et al (2010) Primary use of sirolimus-eluting stents in the infrapopliteal arteries. J Endovasc Ther 17(4):480\u2013487","journal-title":"J Endovasc Ther"},{"issue":"2","key":"370_CR17","first-page":"169","volume":"2","author":"D Scheinert","year":"2006","unstructured":"Scheinert D, Ulrich M, Scheinert S, Sax J, Braunlich S, Biamino G (2006) Comparison of sirolimus-eluting vs. bare-metal stents for the treatment of infrapopliteal obstructions. EuroIntervention 2(2):169\u2013174","journal-title":"EuroIntervention"},{"issue":"1","key":"370_CR18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1161\/CIRCOUTCOMES.108.793406","volume":"2","author":"GA Diamond","year":"2009","unstructured":"Diamond GA, Kaul S (2009) Cost, effectiveness, and cost-effectiveness. Circ Cardiovasc Qual Outcomes 2(1):49\u201354","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"7","key":"370_CR19","doi-asserted-by":"crossref","first-page":"826","DOI":"10.4244\/EIJV5I7A138","volume":"5","author":"E Remak","year":"2010","unstructured":"Remak E, Manson S, Hutton J, Brasseur P, Olivier E, Gershlick A (2010) Cost-effectiveness of the Endeavor stent in de novo native coronary artery lesions updated with contemporary data. EuroIntervention 5(7):826\u2013832","journal-title":"EuroIntervention"},{"issue":"6","key":"370_CR20","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1262-3636(07)70154-4","volume":"30","author":"WK Redekop","year":"2004","unstructured":"Redekop WK, Stolk EA, Kok E, Lovas K, Kalo Z, Busschbach JJ (2004) Diabetic foot ulcers and amputations: estimates of health utility for use in cost-effectiveness analyses of new treatments. Diabetes Metab 30(6):549\u2013556","journal-title":"Diabetes Metab"},{"issue":"4","key":"370_CR21","doi-asserted-by":"crossref","first-page":"901","DOI":"10.2337\/diacare.27.4.901","volume":"27","author":"MM Ortegon","year":"2004","unstructured":"Ortegon MM, Redekop WK, Niessen LW (2004) Cost-effectiveness of prevention and treatment of the diabetic foot: a Markov analysis. Diabetes Care 27(4):901\u2013907","journal-title":"Diabetes Care"},{"issue":"11","key":"370_CR22","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1007\/s001250100013","volume":"44","author":"G Ragnarson Tennvall","year":"2001","unstructured":"Ragnarson Tennvall G, Apelqvist J (2001) Prevention of diabetes-related foot ulcers and amputations: a cost-utility analysis based on Markov model simulations. Diabetologia 44(11):2077\u20132087","journal-title":"Diabetologia"}],"container-title":["CardioVascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-012-0370-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00270-012-0370-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-012-0370-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T13:56:45Z","timestamp":1558706205000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00270-012-0370-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,14]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["370"],"URL":"https:\/\/doi.org\/10.1007\/s00270-012-0370-8","relation":{},"ISSN":["0174-1551","1432-086X"],"issn-type":[{"value":"0174-1551","type":"print"},{"value":"1432-086X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,14]]}}}